CTSO
CTSO
NASDAQ · Health Care

Cytosorbents Corp

$4.87
-0.50 (-9.31%)
As of Nov 14, 10:53 PM ET ·
Financial Highlights (FY 2026)
Revenue
40.15M
Net Income
-8,881,045
Gross Margin
71.5%
Profit Margin
-22.1%
Rev Growth
+2.2%
D/E Ratio
2.82
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 71.5% 71.5% 39.9% 39.9%
Operating Margin -41.3% -37.2% 7.7% 9.4%
Profit Margin -22.1% -21.0% 5.8% 6.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 40.15M 39.27M 13.44M 11.40M
Gross Profit 28.70M 28.07M 5.36M 4.54M
Operating Income -16,582,198 -14,598,433 1.03M 1.07M
Net Income -8,881,045 -7,818,586 783.9K 740.1K
Gross Margin 71.5% 71.5% 39.9% 39.9%
Operating Margin -41.3% -37.2% 7.7% 9.4%
Profit Margin -22.1% -21.0% 5.8% 6.5%
Rev Growth +2.2% +2.2% -9.4% -6.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 6.25M 6.25M 11.74M 10.77M
Total Equity 2.21M 2.21M 22.15M 20.33M
D/E Ratio 2.82 2.82 0.53 0.53
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -15,246,462 -14,168,188 1.54M 1.35M
Free Cash Flow — — 1.21M 903.7K